Global Nicotinamide Riboside Hydrogen Malate (NR-HM) Market Growth 2025-2031

The global Nicotinamide Riboside Hydrogen Malate (NR-HM) market size is predicted to grow from US$ 24.8 million in 2025 to US$ 32.3 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.

Nicotinamide Riboside Hydrogen Malate (NR-HM), also known as nicotinamide riboside hydrogen malate, is a saline form of an important bioactive substance ‌1. It has multiple physiological effects such as increasing the concentration of NAD+ (nicotinamide adenine dinucleotide) in tissues, inducing insulin sensitivity, enhancing deacetylase function, and improving mitochondrial health ‌1. In addition, NR-HM is more consistent in appearance and texture, helping to improve the overall quality of the product and the user experience. The crystalline NR-HM can still maintain good stability at higher temperatures, which makes it able to withstand higher temperature conditions during the preparation process, which helps to optimize the production process and improve the production efficiency ‌1. In the United States, niacinamide ribose malate (NR-HM) has received authoritative approval from the U.S. Food and Drug Administration (FDA) as a safe new dietary ingredient (NDI) ‌.

United States market for Nicotinamide Riboside Hydrogen Malate (NR-HM) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Nicotinamide Riboside Hydrogen Malate (NR-HM) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Nicotinamide Riboside Hydrogen Malate (NR-HM) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Nicotinamide Riboside Hydrogen Malate (NR-HM) players cover Bontac Bio-Engineering (Shenzhen) Co., Ltd., Invertin Biotech, Bicells Science Ltd., SENTIANBIO, Wuxi Vega Science Co.. Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Nicotinamide Riboside Hydrogen Malate (NR-HM) Industry Forecast” looks at past sales and reviews total world Nicotinamide Riboside Hydrogen Malate (NR-HM) sales in 2024, providing a comprehensive analysis by region and market sector of projected Nicotinamide Riboside Hydrogen Malate (NR-HM) sales for 2025 through 2031. With Nicotinamide Riboside Hydrogen Malate (NR-HM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotinamide Riboside Hydrogen Malate (NR-HM) industry.

This Insight Report provides a comprehensive analysis of the global Nicotinamide Riboside Hydrogen Malate (NR-HM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide Riboside Hydrogen Malate (NR-HM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide Riboside Hydrogen Malate (NR-HM) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide Riboside Hydrogen Malate (NR-HM) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide Riboside Hydrogen Malate (NR-HM).

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Riboside Hydrogen Malate (NR-HM) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
>99%
＞99.5%

Segmentation by Application:
Food
Health Products
Personal Care

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bontac Bio-Engineering (Shenzhen) Co., Ltd.
Invertin Biotech
Bicells Science Ltd.
SENTIANBIO
Wuxi Vega Science Co.. Ltd
Botanical Cube Inc.
Xi'an Prius Biological Engineering Co.,Ltd
TianMingPharm
Innova GreenTech Inc.
Hygieia Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nicotinamide Riboside Hydrogen Malate (NR-HM) market?

What factors are driving Nicotinamide Riboside Hydrogen Malate (NR-HM) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nicotinamide Riboside Hydrogen Malate (NR-HM) market opportunities vary by end market size?

How does Nicotinamide Riboside Hydrogen Malate (NR-HM) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.